Advanced Enzymes shares fall 8% after weak Q2 FY25 results | Business Upturn

Top Stories

Navin Fluorine Q4 FY26 Results: Profit, revenue beat estimates; EBITDA surges 80% YoY Adani Power Q4 Results: Net profit surges 64% YoY to Rs 4,271 crore, revenue flat at Rs 14,223 crore Why did Union Bank share price fell nearly 3% sharply today? Explained Dr. Reddy’s just beat every G7 country to generic Ozempic — Canada becomes the first to approve it and an Indian company leads the way Sapphire Foods Q4 FY26 results: Net loss at ₹12.6 crore; margins improve Castrol India Q1 Results: Net profit rises 4% to ₹242 crore; revenue up 9% Indus Towers may pay its first dividend in over 4 years — board meets April 30 and shares are already reacting TCS partners with Siemens Energy to drive AI-led industrial transformation and data centre solutions Navin Fluorine Q4 FY26 Results: Profit, revenue beat estimates; EBITDA surges 80% YoY Adani Power Q4 Results: Net profit surges 64% YoY to Rs 4,271 crore, revenue flat at Rs 14,223 crore Why did Union Bank share price fell nearly 3% sharply today? Explained Dr. Reddy’s just beat every G7 country to generic Ozempic — Canada becomes the first to approve it and an Indian company leads the way Sapphire Foods Q4 FY26 results: Net loss at ₹12.6 crore; margins improve Castrol India Q1 Results: Net profit rises 4% to ₹242 crore; revenue up 9% Indus Towers may pay its first dividend in over 4 years — board meets April 30 and shares are already reacting TCS partners with Siemens Energy to drive AI-led industrial transformation and data centre solutions

HOME /FINANCE/STOCK MARKET

Advanced Enzyme Technologies shares dropped over 8% in morning trading following disappointing Q2 FY25 results.

The company reported a 7.4% year-over-year revenue drop to ₹146.1 crore, down from ₹157.8 crore in Q2 FY24. Quarter-over-quarter, revenue also declined by 5.5% from ₹154.5 crore in Q1 FY25.

Net profit for Q2 FY25 was ₹33.4 crore, a 5.1% decrease from ₹35.2 crore in the same period last year, and a 4.5% dip from ₹34.9 crore in Q1 FY25.

As of 9:20 am, Advanced Enzyme shares were trading 8.45% lower at Rs 445.00 on the NSE.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

Add us as preferred source on Google